User profiles for Francois Benard
François BénardProfessor of Radiology, University of British Columbia Verified email at bccrc.ca Cited by 11091 |
Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results
Respiratory motion may reduce the sensitivity of 18 F-FDG PET for the detection of small
pulmonary nodules close to the base of the lungs. This motion also interferes with attempts to …
pulmonary nodules close to the base of the lungs. This motion also interferes with attempts to …
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary …
Objectives : We conducted a randomized trial to assess the effectiveness of F-18-fluorodeoxyglucose
(FDG) positron emission tomography (PET)-assisted management in patients with …
(FDG) positron emission tomography (PET)-assisted management in patients with …
[HTML][HTML] Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation
Transmembrane protease, serine 2 (TMPRSS2) has been identified as key host cell factor
for viral entry and pathogenesis of SARS-CoV-2. Specifically, TMPRSS2 proteolytically …
for viral entry and pathogenesis of SARS-CoV-2. Specifically, TMPRSS2 proteolytically …
Prognostic value of FDG PET imaging in malignant pleural mesothelioma
Despite several attempts at treating malignant pleural mesothelioma with various modalities,
mortality remains high, with median survival between 12 and 18 mo. This disease may …
mortality remains high, with median survival between 12 and 18 mo. This disease may …
[HTML][HTML] Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography
Background:The diagnosis of malignant mesothelioma is a challenging medical problem.
CT often cannot differentiate between benign diffuse pleural thickening and malignant …
CT often cannot differentiate between benign diffuse pleural thickening and malignant …
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in …
R Hustinx, RJ Smith, F Benard, DI Rosenthal… - European journal of …, 1999 - Springer
Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) studies imaging
FDG PET imaging is used to detect and stage head and neck cancers. However, the …
FDG PET imaging is used to detect and stage head and neck cancers. However, the …
[PDF][PDF] A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer
…, SF Shariat, C Jeldres, M Graefen, F Bénard… - Journal of Clinical …, 2007 - Citeseer
Purpose Candidates for definitive therapy for localized prostate cancer (PCa) should have
life expectancy (LE) in excess of 10 years. However, LE estimation is difficult. To circumvent …
life expectancy (LE) in excess of 10 years. However, LE estimation is difficult. To circumvent …
Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation
…, M Lépine, J Verreault, F Bénard - Journal of Nuclear …, 2003 - Soc Nuclear Med
Detection of relapse after completion of therapy in patients with Hodgkin’s disease (HD) and
non-Hodgkin’s lymphomas (NHL) constitutes an important challenge in modern medical …
non-Hodgkin’s lymphomas (NHL) constitutes an important challenge in modern medical …
An Organotrifluoroborate for Broadly Applicable One‐Step 18F‐Labeling
A new zwitterionic organotrifluoroborate is appended to three radiosynthons that afford
undergo facile bioconjugation to several clinically relevant peptides and one enzyme inhibitor. …
undergo facile bioconjugation to several clinically relevant peptides and one enzyme inhibitor. …
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial
…, M Freeman, N Racine, F Benard… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives : We sought to determine: 1) whether F-18-fluorodeoxyglucose (FDG) positron
emission tomography (PET) parameters identify high-risk patients who gain benefit from …
emission tomography (PET) parameters identify high-risk patients who gain benefit from …